We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us

HORIBA Medical

HORIBA ABX designs, develops and distributes worldwide, in vitro diagnostic systems for biological analysis in medica... read more Featured Products: More products

Download Mobile App




Two Automated Hematology Analyzers Compared for Performance

By LabMedica International staff writers
Posted on 17 Dec 2020
A complete blood count (CBC) is a highly automated laboratory test. More...
The use of highly advanced measurement methods increases the accuracy and sensitivity of the determination of individual hematological parameters, especially in the case of white blood cells differentiation.

It is important that the results of laboratory tests obtained using automated analyzers, which are currently able to perform more than 1,000 tests per day, are comparable, repeatable and reliable regardless of the analyzer used and the laboratory in which the analysis was performed.

Medical Laboratorians at the Medical University of Warsaw (Warsaw, Poland) collected 241 peripheral blood samples from adult patients. Samples of peripheral blood came from both healthy patients and those suffering from various pathologies. To perform comparative analysis of hematological parameters, complete blood count with leukocyte differentiation (CBC+ 5-DIFF) and a complete blood count (CBC) without leukocyte differentiation were used.

The complete blood count results were obtained using two automated hematology analyzers: the XN-2000 (Sysmex Corporation, Kobe, Japan) and the Yumizen H2500 (Horiba, Kyoto, Japan). The XN-2000 uses the following methods of fluorescent flow to determine all tested hematological parameters: cytometry, impedance and optical cytometry. Impedance method to count red blood cells (RBC) and platelets, and has an optical measurement channel for reticulocytes in which platelet count can also be measured. The Yumizen H2500 is a quantitative, multi-parameter, automatic hematological analyzer. It uses the double hydrodynamic focusing method, which includes measurement of polychromatic light absorbance and the impedance method.

The scientists reported that reliable leukocyte differentiation results were obtained for blood samples in which the number of white blood cells perceived using an automatic hematological analyzer was within the detection limits for both analyzers. Statistically significant differences were found for four hematological parameters: eosinophil count, immature granulocytes, mean corpuscular hemoglobin concentration (MCHC) and platelet distribution width (PDW).

The comparative study showed agreement between measurements of complete blood count parameters such as leukocyte count (WBC), red blood cell count (RBC), hemoglobin concentration (HGB), hematocrit (HCT), mean corpuscular volume (MCV), mean corpuscular hemoglobin (mean cell hemoglobin, MCH), red blood cell distribution width (RDW), platelet count (PLT), mean platelet volume (MPV), and plateletcrit (PCT).

The authors concluded that due to the existence of variability between the results obtained from different hematology analyzers, it is recommended that patient samples be analyzed in the same laboratory using the same analyzer, in order to avoid obtaining divergent results that could be misinterpreted. Incorrect interpretation may affect further clinical management and be a source of uncertainty. The study was published in the November, 2020 issue of the journal Practical Laboratory Medicine.

Related Links:
Medical University of Warsaw
Sysmex Corporation
Horiba



New
Gold Member
Blood Gas Analyzer
Stat Profile pHOx
POC Helicobacter Pylori Test Kit
Hepy Urease Test
New
ESR Analyzer
TEST1 2.0
New
Rapid Test Reader
DIA5000
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to LabMedica.com and get access to news and events that shape the world of Clinical Laboratory Medicine.
  • Free digital version edition of LabMedica International sent by email on regular basis
  • Free print version of LabMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of LabMedica International in digital format
  • Free LabMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Immunology

view channel
Image: Prof. Nicholas Schwab has found a biomarker that can predict treatment outcome of glatirameracetate in MS patients (Photo courtesy of Uni MS - M. Ibrahim)

Simple Genetic Testing Could Predict Treatment Success in Multiple Sclerosis Patients

Multiple sclerosis (MS) patients starting therapy often face a choice between interferon beta and glatiramer acetate, two equally established and well-tolerated first-line treatments. Until now, the decision... Read more

Microbiology

view channel
Image: New diagnostics could predict a woman’s risk of a common sexually transmitted infection (Photo courtesy of 123RF)

New Markers Could Predict Risk of Severe Chlamydia Infection

Chlamydia trachomatis is a common sexually transmitted infection that can cause pelvic inflammatory disease, infertility, and other reproductive complications when it spreads to the upper genital tract.... Read more

Pathology

view channel
Image: (A) Normal skin and (B) possible pathology in ALS skin (Photo courtesy of Biomolecules and Biomedicine (2025) DOI: 10.17305/bb.2025.12100)

Skin-Based Biomarkers to Enable Early Diagnosis of Amyotrophic Lateral Sclerosis

Amyotrophic lateral sclerosis (ALS) is a progressive neurodegenerative disease that damages motor neurons in the brain and spinal cord, causing muscle weakness, paralysis, and death within three to five... Read more
Copyright © 2000-2025 Globetech Media. All rights reserved.